Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Amylyx Pharmaceuticals (AMLX) SEC Filings & 10K Form

Amylyx Pharmaceuticals logo
$8.41 +0.11 (+1.33%)
Closing price 04:00 PM Eastern
Extended Trading
$8.36 -0.05 (-0.59%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Amylyx Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
08/12/2025
8:07 AM		Adage Capital Management, L.P. (Filed by)
Amylyx Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
08/07/2025
6:03 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
6:15 AM		Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2025
10:21 AM		Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G
07/17/2025
6:44 PM		Amylyx Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G
06/25/2025
4:24 PM		Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
05/12/2025
8:05 AM		Adage Capital Management, L.P. (Filed by)
Amylyx Pharmaceuticals (Subject)
Form SCHEDULE 13G
05/08/2025
6:01 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:04 AM		Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
6:05 AM		Amylyx Pharmaceuticals (Filer)
Form DEF 14A
04/24/2025
6:09 AM		Amylyx Pharmaceuticals (Filer)
Form DEFA14A
04/24/2025
6:13 AM		Amylyx Pharmaceuticals (Filer)
Form ARS
04/02/2025
4:22 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:12 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:14 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:52 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
11:15 PM		Amylyx Pharmaceuticals (Filer)
Form EFFECT
03/24/2025
3:15 PM		Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:32 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:34 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:28 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:28 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:30 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:32 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:32 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:30 AM		Amylyx Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/04/2025
5:24 AM		Amylyx Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
5:07 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
5:14 AM		Amylyx Pharmaceuticals (Filer)
Form POSASR
02/26/2025
3:35 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM		Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
Form SCHEDULE 13G/A
02/06/2025
7:17 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:54 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:55 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:58 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
3:55 PM		Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:53 PM		Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/10/2025
4:13 PM		Amylyx Pharmaceuticals (Filer)
Form 424B5
01/10/2025
4:23 PM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:05 AM		Amylyx Pharmaceuticals (Filer)
Form 424B5
01/08/2025
4:29 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
01/08/2025
4:26 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:50 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:21 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
7:22 AM		Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:07 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
6:24 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
9:56 AM		Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/25/2024
4:38 PM		Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
10/17/2024
8:12 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
5:48 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:50 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:53 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:53 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
4:56 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:39 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:30 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:55 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4/A
09/05/2024
6:26 PM		Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
5:49 PM		Amylyx Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AMLX) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...
Brownstone Research | Sponsored
But this $20 American company could control the secret
The "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...
The Oxford Club | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Generate up to $5,000/month with 10X less money?
The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...
Investors Alley | Sponsored